The startup specializes in gene editing techniques for pigs, specifically targeting modifications that facilitate xenotransplantation of organs, tissues, and cells. This approach aims to provide viable transplant options for patients suffering from organ failure, thereby improving their health outcomes and survival rates.
Funding
$200K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The demand for organs significantly exceeds the available supply from human donors, leading to long waiting lists and a critical need for alternative transplantation solutions. Patients facing organ failure often experience prolonged periods of uncertainty and deteriorating health while awaiting a suitable match. The gap between organ supply and demand continues to widen despite efforts to promote human organ donation.
Solution
New Organs Biotech addresses the global organ shortage by pioneering xenotransplantation, using gene editing technologies to produce pigs with organs compatible for human transplant. By modifying the pig genome, the company aims to eliminate hyperacute immune rejection and increase the compatibility of porcine organs with the human immune system. This approach involves leveraging advanced gene editing techniques and a deep understanding of both pig and human genomes to create "human compatible pigs." The ultimate goal is to provide a scalable and sustainable source of organs, tissues, and cells for patients in critical need of transplants, thereby alleviating the organ shortage crisis.
Target Audience
The primary target audience includes patients suffering from organ failure who are on waiting lists for transplants, as well as medical professionals and institutions involved in transplantation procedures.
Features
- Utilizes gene editing technologies to modify pig genomes for human compatibility.
- Focuses on eliminating hyperacute immune rejection in xenotransplantation.
- Aims to increase the availability of organs, tissues, and cells for transplantation.
- Employs knowledge of pig and human genomes to enhance compatibility.